Portfolio

  • The product portfolio will be based upon the market demands based on disease trends, prescribing patterns and sales data.​
  • The impetus shall be towards life saving, critical care products.​
  • Highly differentiated super generics,niche and unique value added products shall make the topline.​
  • Focus on Crash cart injectables,ER(Emergency Room) injectables.​
  • NDDS, additional strength products and vial to PFS conversion to maximize the portfolio​
  • Animal healthcare veterinary injectables to fulfill the unmet needs of the markets.​
  • Our goal is to provide quality and quantity as per the market trends.

INSIGHT INTO PRODUCT PORTFOLIO

Product Type:

  • Monoclonal Antibodies
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Chemotherapy Agents
  • Others

Application:

  • Oncology
  • Infectious Diseases
  • Diabetes
  • Blood disorders
  • Hormonal Disorders
  • Musculoskeletal Disorders
  • CNS Diseases
  • Pain Management
  • Cardiovascular Diseases